Quantification of the clinical modifiers impacting high-density lipoprotein cholesterol in the community: Personalized medicine research project

Preventive Cardiology

Volumn 13, Issue 2, 2010, Pages 63-68

  Wilke, Russell A ^a   Berg, Richard L ^b   Linneman, James G ^b   Peissig, Peggy ^b   Starren, Justin ^b   Ritchie, Marilyn D ^c   McCarty, Catherine A ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b MARSHFIELD CLINIC   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COMMUNITY CARE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EFFECT SIZE; FEMALE; GENE IDENTIFICATION; GENETIC ALGORITHM; GENETIC DATABASE; GENETIC MARKER; HOMEOSTASIS; HUMAN; INDIVIDUALIZATION; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PHENOTYPE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; SEX DIFFERENCE; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CHOLESTEROL, HDL; DATABASES, FACTUAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; PREGNANCY; PREVENTIVE MEDICINE; PRIMARY PREVENTION; PROGRAM DEVELOPMENT; SECONDARY PREVENTION; YOUNG ADULT;

EID: 77952025317     PISSN: 1520037X     EISSN: 17517141     Source Type: Journal    
DOI: 10.1111/j.1751-7141.2009.00055.x     Document Type: Article

References (23)

1. Wilson PW, Garrison RJ, Castelli WP. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. Am J Cardiol. 1980, 46:649-654.
2. Wilke RA, Carrillo MW, Ritchie MD. Pacific Symposium on Biocomputing - computational approaches for pharmacogenomics. Pharmacogenomics. 2005, 6:111-113.
3. Wilke RA, Lin DW, Roden DM. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat Rev Drug Discov. 2007, 6:904-916.
4. Wilke RA, Mareedu RK, Moore JH. The pathway less traveled-moving from candidate genes to candidate pathways in the analysis of genome-wide data from large scale pharmacogenetic association studies. Curr Pharmacogenomics Person Med. 2008, 6:150-159.
5. Kathiresan S, Melander O, Guiducci C. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008, 40:189-197.
6. Kissebah AH, Sonnenberg GE, Myklebust J. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci USA. 2000, 97:14478-14483.
7. Sonnenberg GE, Krakower GR, Martin LJ. Genetic determinants of obesity-related lipid traits. J Lipid Res. 2004, 45:610-615.
8. Smith EM, Wang X, Littrell J. Comparison of linkage disequilibrium patterns between the HapMap CEPH samples and a family-based cohort of Northern European descent. Genomics. 2006, 88:407-414.
9. Baye TM, Zhang Y, Smith E. Genetic variation in cannabinoid receptor 1 (CNR1) is associated with derangements in lipid homeostasis, independent of body mass index. Pharmacogenomics. 2008, 9:1647-1656.
10. McCarty CA, Wilke RA, Giampietro PF. Marshfield Clinic Personalized Medicine Research Project PMRP: Design, Methods and Recruitment for a large population-based biobank. Per Med. 2005, 2:49-79.
11. Kaiser J. Biobanks. Population databases boom, from Iceland to the U.S. Science. 2002, 298:1158-1161.
12. McCarty CA, Peissig P, Wilke RA. The Marshfield Clinic Personalized Medicine Research Project (PMRP) 2008 - scientific update and lessons learned in the first six years. Per Med. 2008, 5:1-13.
13. McCarty CA, Mukesh BN, Giampietro PF. Healthy People 2010 disease prevalence in the Marshfield Clinic Personalized Medicine Research Project: opportunities for public health genomic research. Per Med. 2007, 4:183-190.
14. McDowell MA, Fryar CD, Hirsch R. Anthropometric reference data for children and adults: U.S. population, 1999-2002. Adv Data. 2005, 7:1-5.
15. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med. 1992, 11:1305-1319.
16. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults executive summary of the third report of the national cholesterol education program (NCEP: Adult Treatment Panel III). JAMA. 2001, 285:2486-2497.
17. Bittner V. Perspectives on dyslipidemia and coronary heart disease in women. J Am Coll Cardiol. 2005, 46:1628-1635.
18. Newman DL, Abney M, Dytch H. Major loci influencing serum triglyceride levels on 2q14 and 9p21 localized by homozygosity-by-descent mapping in a large Hutterite pedigree. Hum Mol Genet. 2003, 12:137-144.
19. Wilson PW, Anderson KM, Harris T. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol. 1994, 49:M252-M257.
20. Hegele RA. Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet. 2009, 10:109-121.
21. Hegele RA, Pollex RL. Hypertriglyceridemia: phenomics and genomics. Mol Cell Biochem 2009, 326:35-43.
22. Nissen SE, Tardif JC, Nicholls SJ. Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med. 2007, 356:1304-1316.
23. Wilke RA, Berg RL, Peissig P. Use of an electronic medical record for the identification of research subjects with diabetes mellitus. Clin Med Res. 2007, 5:1-7.